MS4-55625-63141
4 vaccinations
5 coded responses
46 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 029 / RI
- Registered
- 2020-12-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-24
Registered in v-safe
-
2020-12-24
Dose 1 — Pfizer-BioNTech
- 2020-12-25
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
-
2021-01-07
Survey response — day 14, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: FairFree text: Runny nose, sore throat, fatigue, headache. Please note that I had to switch back and forth from night shift to day shift back to night shift, which is what I attribute these symptoms to.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-14
-
2021-01-15
Dose 2 — Pfizer-BioNTech
- 2021-01-15
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-18
- 2021-01-19
- 2021-01-21
- 2021-01-22
- 2021-01-29
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-04-16
- 2021-07-16
-
2021-09-29
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-09-29
-
2021-09-30
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-05
- 2021-10-06
- 2021-10-13
- 2021-10-20
- 2021-10-27
-
2021-11-05
Survey response — day 35, dose 3MedDRA: Ocular hyperaemia — Feeling: GoodFree text: Red eye unilateralMedDRA releases: 2024-11 · check-in free text available
- 2021-11-10
- 2021-12-29
- 2022-03-30
-
2022-09-20
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-24
- 2022-09-25
- 2022-09-29
- 2022-10-06
-
2022-10-18
Survey response — day 28, dose 4MedDRA: Nasopharyngitis, SARS-CoV-2 test negative — Feeling: GoodFree text: Cold symptoms with negative covid antigen test but did not get pcr.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-25
- 2022-11-01
-
2022-12-20
Survey response — 3 months, dose 4MedDRA: Gastroenteritis, Upper respiratory tract infection — Feeling: Good · Be unable to work or attend schoolFree text: URI and gastroenteritisMedDRA releases: 2024-11 · check-in free text available
-
2023-03-21
Survey response — 6 months, dose 4MedDRA: COVID-19, Pregnancy — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-03-21
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2023-03-22
-
2023-03-22
Call successfulCompleted over the phone
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-24 | Pfizer-BioNTech | |
| 2 | 2021-01-15 | Pfizer-BioNTech | |
| 3 | 2021-09-29 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-20 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 1 — day 14, dose 1
Symptoms: Runny nose, sore throat, fatigue, headache. Please note that I had to switch back and forth from night shift to day shift back to night shift, which is what I attribute these symptoms to.
Release 10 — day 35, dose 3
Symptoms: Red eye unilateral
Release 12 — day 28, dose 4
Symptoms: Cold symptoms with negative covid antigen test but did not get pcr.
Release 12 — 3 months, dose 4
Symptoms: URI and gastroenteritis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastroenteritis | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Ocular hyperaemia | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release